Q3 FY2025 · Press release
U.S. FDA Approves Agiosâ AQVESME⢠(mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia · December 24, 2025 · 4 pages
Read Agios Pharmaceuticals, Inc.'s results firsthand
Preview the first 2 pages of this press release
Create a free account to start reading
Full documents are included with Professional